Aurora Cannabis Inc. (NYSE:ACB – Get Free Report) was the recipient of some unusual options trading on Thursday. Investors purchased 5,745 call options on the company. This is an increase of 105% compared to the typical daily volume of 2,803 call options.
Aurora Cannabis Trading Up 3.4 %
Shares of NYSE:ACB opened at $0.48 on Friday. The company has a market cap of $183.12 million, a P/E ratio of -0.92 and a beta of 2.60. The company has a debt-to-equity ratio of 0.33, a current ratio of 4.08 and a quick ratio of 3.16. Aurora Cannabis has a 1 year low of $0.43 and a 1 year high of $1.67. The stock’s fifty day moving average price is $0.53 and its 200-day moving average price is $0.62.
Aurora Cannabis (NYSE:ACB – Get Free Report) last released its quarterly earnings data on Thursday, August 10th. The company reported ($0.04) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.04. The firm had revenue of $55.92 million during the quarter, compared to analyst estimates of $46.80 million. Aurora Cannabis had a negative return on equity of 30.47% and a negative net margin of 88.27%. Sell-side analysts expect that Aurora Cannabis will post -0.11 earnings per share for the current year.
Hedge Funds Weigh In On Aurora Cannabis
Aurora Cannabis Company Profile
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Read More
- Five stocks we like better than Aurora Cannabis
- What is the NASDAQ Stock Exchange?
- 3 Takeaways from the August Inflation ReportĀ
- How to Buy Gold Stock and Invest in Gold
- On Fire: 5 Best Artificial Intelligence Penny Stocks
- 5 Top Rated Dividend Stocks to Consider
- 6 Cybersecurity Stocks: Which is the Best to Buy?
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.